Microbot Medical Inc Stock News

HINGHAM, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance for a second

HINGHAM, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance for a second patent application covering the Companys LIBERTY ® Robotic System. Globally, the Company now has 46 patents issued/allowed and 24 pending patent applications and is continuously submitting applications to protect its Intellectual Property.

Microbot Medical (NASDAQ:MBOT) announced its earnings results on Monday. The biotechnology company reported ($0.36) EPS for the quarter, hitting the consensus estimate of ($0.36), Fidelity Earnings reports. Microbot Medical stock traded down $0.05 during mid-day trading on Wednesday, hitting $6.73. The stock had a trading volume of 1 shares, compared to its average volume of []

HINGHAM, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance covering the C

HINGHAM, Mass., June 04, 2021 (GLOBE NEWSWIRE) -- Global patent jurisdictions continue to recognize Microbot Medical Inc.'s (Nasdaq: MBOT) innovative ‘One & Done' guidewire technology, as the Israel

Scientific Advisory Board Expanded with Additions of Global Medical Pioneers and Distinguished Thought Leaders Scientific Advisory Board Expanded with Additions of Global Medical Pioneers and Distingu

Results Validate Findings of Initial Study; End Points Achieved with No Intraoperative Adverse Events

HINGHAM, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that Harel Gadot, CEO, President and Chief Executive Officer, will be presenting virtually at two upco

HINGHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company's continued e

Webcast to be Held on Thursday November 12 th at 2:00pm ET

The

Microbot Medical Inc. (Nasdaq: MBOT) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent

Microbot Medical Inc (NASDAQ:MBOT) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $6.76 and traded as high as $7.23. Microbot Medical s

Microbot Medical (NASDAQ:MBOT) and Coherus Biosciences (NASDAQ:CHRS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength